Philips para monitor G30 E
Philips Goldway G30E is a cost-effective, easy to learn, pre-configured bedside monitor that provides reliable measurements. It is a highly reliable and versatile patient monitoring device that saves precious time in determining the best course of care.
- FAQs (0)
- Reviews (0)
Philips para monitor G30E
Clinicians need to respond swiftly to rapid changes in their patient’s condition. Having a highly reliable, versatile patient monitoring solution on hand saves precious time in determining the best course of care. Philips Goldway G30E is your choice for a cost-effective, easy to learn, pre-configured bedside monitor that provides reliable measurements (Philips ST/AR ECG and FAST-SpO₂).
|Dimensions||12.5 × 10.5 × 5.2 cm|
1. Advanced functionalities
To accommodate different clinical environments, the G30E delivers real-time data about cardiac and respiratory conditions.
2. Ease of use
The monitor has a 10.4” display with flexible display modes, such as big number display mode, minitrend, OxyCRG, as well as auto waveform channel height adjustment function to fit various clinical settings.
3. Networking and data management
The G30E comes standard with LAN networking capabilities for facilities looking to create a network with a bi-directional communication with Philips Efficia CMS200 central monitoring system or require data output in HL7 format.
4. Compact and cost-effective
Built according to Philips exacting quality standards, the G30E patient monitor offers market-proven essential parameters in a compact, cost-effective monitor to provide accurate measurement results within your tight budget.
5. Works with Efficia consumables
The G30E patient monitor is designed to be compatible with Philips Efficia consumables, which are also used on Philips Efficia CM series bedside patient monitors, to lower your total cost of ownership by sharing Philips consumables across different care settings.
- 3-lead or 5-lead selectable
Lead selection, 3-lead
- I, II, III
|ST measurement range|
There are no reviews yet.